Tandem Diabetes Care Inc (TNDM)
Profitability ratios
Return on sales
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross profit margin | 46.21% | 43.69% | 49.06% | 49.28% | 49.17% | 50.55% | 51.19% | 50.94% | 51.54% | 52.00% | 52.69% | 53.41% | 53.53% | 53.42% | 53.17% | 52.32% | 52.23% | 52.43% | 52.56% | 53.55% |
| Operating profit margin | -9.36% | -13.72% | -17.47% | -19.10% | -20.31% | -17.45% | -19.05% | -15.60% | -11.59% | -8.03% | -1.08% | 1.28% | 3.06% | 4.32% | 3.28% | 0.44% | -1.60% | -5.57% | -7.18% | -4.90% |
| Pretax margin | -8.67% | -12.65% | -16.50% | -17.69% | -29.46% | -26.58% | -28.05% | -25.17% | -11.59% | -8.30% | -1.62% | 0.63% | 2.26% | 3.30% | 1.09% | -4.92% | -7.27% | -11.52% | -10.74% | -4.16% |
| Net profit margin | -9.06% | -13.02% | -17.15% | -18.37% | -29.77% | -27.02% | -28.40% | -25.64% | -11.81% | -8.59% | -1.72% | 0.80% | 2.21% | 3.29% | 1.08% | -4.53% | -6.89% | -11.10% | -10.29% | -4.22% |
Tandem Diabetes Care Inc's profitability ratios exhibit fluctuations over the period under review. The gross profit margin shows a general decreasing trend from 53.55% on March 31, 2020, to 46.21% on December 31, 2024. This suggests a decline in the company's ability to generate profits on sales over the period.
The operating profit margin, on the other hand, fluctuates from negative figures to positive, indicating inconsistencies in operational efficiency. The margin ranges from -20.31% on December 31, 2023, to 4.32% on September 30, 2021. This implies that the company experienced periods of losses and gains in operating profitability.
Similarly, the pretax margin displays variability, moving from -29.46% on December 31, 2023, to 3.30% on September 30, 2021. The trend suggests the company's ability to generate profits before tax was unstable over the period.
Lastly, the net profit margin fluctuates, ranging from -29.77% on December 31, 2023, to 3.29% on September 30, 2021. This indicates inconsistency in the company's ability to convert revenue into net profit.
Overall, the analysis of profitability ratios for Tandem Diabetes Care Inc shows fluctuations and inconsistencies in various margin metrics over the review period, highlighting the company's changing financial performance and challenges in maintaining stable profitability levels.
Return on investment
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating return on assets (Operating ROA) | -10.24% | -13.95% | -14.83% | -15.63% | -15.94% | -14.32% | -15.90% | -12.99% | -8.82% | -6.06% | -0.80% | 0.93% | 2.38% | 3.36% | 2.50% | 0.32% | -1.11% | -3.64% | -4.78% | -5.62% |
| Return on assets (ROA) | -9.92% | -13.24% | -14.56% | -15.03% | -23.37% | -22.18% | -23.71% | -21.35% | -8.99% | -6.49% | -1.27% | 0.58% | 1.72% | 2.56% | 0.82% | -3.26% | -4.80% | -7.24% | -6.85% | -4.84% |
| Return on total capital | -32.82% | -48.73% | -51.73% | -51.86% | -67.08% | -62.23% | -65.39% | -57.17% | -19.79% | -14.17% | -1.40% | 2.41% | 5.13% | 7.23% | 4.60% | -4.94% | -7.26% | -13.20% | -15.45% | -8.16% |
| Return on equity (ROE) | -36.50% | -53.33% | -58.36% | -58.20% | -70.98% | -66.39% | -68.18% | -60.15% | -21.50% | -16.10% | -2.93% | 1.35% | 3.59% | 5.58% | 1.89% | -7.84% | -9.39% | -14.92% | -15.77% | -8.03% |
Tandem Diabetes Care Inc's profitability ratios have shown significant fluctuations over the quarters.
- Operating return on assets (Operating ROA) has been negative for the majority of the quarters, with a notable improvement in the most recent quarters, reaching a positive value in March 31, 2023, and June 30, 2023, before declining again. This indicates challenges in generating profits from its operational assets.
- Return on assets (ROA) has also been predominantly negative, showcasing the company's struggle in generating profits from its total assets. The ratio saw a severe decline in March 31, 2023, and December 31, 2023, where it reached its lowest points.
- Return on total capital shows a similar trend of negative values, signifying the company's inability to earn adequate returns with the capital invested. The ratio had a sharp drop in March 31, 2023, and continued to decrease until December 31, 2024.
- Return on equity (ROE) exhibited fluctuations throughout the quarters, with negative values persisting for the most part. There were intermittent improvements, such as in June 30, 2021, and December 31, 2021, but the ratio generally trended downward, reaching its lowest points in the quarters ending March 31, 2023, and December 31, 2023.
Overall, Tandem Diabetes Care Inc's profitability ratios reflect a challenging financial performance, with periods of improvement interspersed with significant downturns. Efforts may be needed to enhance operational efficiency and generate better returns for its investors.